Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > New Board Members
View:
Post by WarrantOfficer on Jul 26, 2021 9:33pm

New Board Members

Management strengthing up the board with expertise in business development and management, joint ventures, initiating new operation start ups, merger and aqusition activities. A clear indication the direction they are heading.  Zero pharma experience with the two new members though. I read the MD&A. There was no insight as to how the clinical trials are proceeding, unfortunatley not much to highlight, ......some standard doom and gloom. They did mention ThinQ for the first time in a  long time. Utilizing a production facitily in India is a strategic win. Voyageur is going to require several more million dollars to advance their strategic plans. Expect further dilution, how much will depend upon SP.
Comment by biggdogg on Jul 26, 2021 9:52pm
Management is smart, i would expect all sorts of pharmaceutical expertise to continue to come into the company. The Dash group are contrast experts, I am sure they have more expetise coming as they advance. 
Comment by Billybub on Jul 27, 2021 9:19am
The best option is for the company to seek out a suitor with deep pockets perhaps BHC or SGIOY. can't  grow without a huge financial injection. I suspect a possible buy out or "merger" in the next 6 months to 1year
Comment by Billybub on Jul 28, 2021 9:23am
Yes dilution is going to happen for sure. if they need $5 million they will have to issue 100million shares at 5cents. we can see what happens by the last pp. issue at 15 cents -now 10.5 cents. best bet is to sell out
Comment by EDMINNEMA on Jul 28, 2021 10:00am
thhey wont raise at .05, that be suicide
Comment by 2021Gamble on Jul 28, 2021 10:41am
well, while I agree... Anon has been definately driving the price down all month.  The have a net volume of -404500 shares now for the month of July, and the sell average is only 0.106 so they've been hitting it hard. Broker    Broker Name    Buy Average    Buy Volume    Sell Average    Sell Volume   ...more  
Comment by 2021Gamble on Jul 28, 2021 10:42am
you say "best bet is to sell out"....I'm of the opinion, that the best bet is to buy more.  So I have, both yesterday and today... cheers!!
Comment by EDMINNEMA on Jul 28, 2021 12:14pm
thhey wont raise at .05, that be suicide
Comment by 2021Gamble on Jul 28, 2021 12:20pm
Oh, I agree - especially with the private placement from just a few months ago at 0.15 .... just trying to point out that the only reason the price is actually this low, and below the last PP is because Anon has been selling it down aggressively.... But, I also see alot of buyers anywhere below that 0.15 PP.  I think this is a great deal for VM.  I never thought I would see the teens ...more  
Comment by EDMINNEMA on Jul 28, 2021 12:25pm
anon has been selling because there has been no real reason o buy. News has been boring to lacklustre. maybe new management well get shiet rolling
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1